163 related articles for article (PubMed ID: 11711531)
21. Transforming growth factor-beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells.
Kanai H; Tanaka T; Aihara Y; Takeda S; Kawabata M; Miyazono K; Nagai R; Kurabayashi M
Circ Res; 2001 Jan; 88(1):30-6. PubMed ID: 11139470
[TBL] [Abstract][Full Text] [Related]
22. SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke.
Springer J; Scholz FR; Peiser C; Groneberg DA; Fischer A
Biol Chem; 2004 Jul; 385(7):649-53. PubMed ID: 15318814
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation.
Pulaski L; Landström M; Heldin CH; Souchelnytskyi S
J Biol Chem; 2001 Apr; 276(17):14344-9. PubMed ID: 11278814
[TBL] [Abstract][Full Text] [Related]
24. Ectopic expression of Smad7 inhibits transforming growth factor-beta responses in vascular smooth muscle cells.
Kato S; Ueda S; Tamaki K; Fujii M; Miyazono K; ten Dijke P; Morimatsu M; Okuda S
Life Sci; 2001 Oct; 69(22):2641-52. PubMed ID: 11712667
[TBL] [Abstract][Full Text] [Related]
25. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.
Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R
J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for inhibitory effects of Smad7 on TGF-β family signaling.
Murayama K; Kato-Murayama M; Itoh Y; Miyazono K; Miyazawa K; Shirouzu M
J Struct Biol; 2020 Dec; 212(3):107661. PubMed ID: 33166654
[TBL] [Abstract][Full Text] [Related]
27. Regulation of transforming growth factor-beta signaling.
Zhu HJ; Burgess AW
Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
[TBL] [Abstract][Full Text] [Related]
28. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells.
Ishisaki A; Yamato K; Hashimoto S; Nakao A; Tamaki K; Nonaka K; ten Dijke P; Sugino H; Nishihara T
J Biol Chem; 1999 May; 274(19):13637-42. PubMed ID: 10224135
[TBL] [Abstract][Full Text] [Related]
29. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif.
Makkar P; Metpally RP; Sangadala S; Reddy BV
J Mol Graph Model; 2009 Apr; 27(7):803-12. PubMed ID: 19157940
[TBL] [Abstract][Full Text] [Related]
30. Localization of Smad6 and Smad7 in the rat kidney and their regulated expression in the anti-Thy-1 nephritis.
Uchida K; Nitta K; Kobayashi H; Kawachi H; Shimizu F; Yumura W; Nihei H
Mol Cell Biol Res Commun; 2000 Aug; 4(2):98-105. PubMed ID: 11170839
[TBL] [Abstract][Full Text] [Related]
31. An essential role for Mad homology domain 1 in the association of Smad3 with histone deacetylase activity*.
Liberati NT; Moniwa M; Borton AJ; Davie JR; Wang XF
J Biol Chem; 2001 Jun; 276(25):22595-603. PubMed ID: 11306568
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta signaling by Smad proteins.
Miyazono K
Cytokine Growth Factor Rev; 2000; 11(1-2):15-22. PubMed ID: 10708949
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.
Osawa H; Nakajima M; Kato H; Fukuchi M; Kuwano H
Anticancer Res; 2004; 24(6):3703-9. PubMed ID: 15736400
[TBL] [Abstract][Full Text] [Related]
34. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
35. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
[TBL] [Abstract][Full Text] [Related]
36. Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling.
Yoshida Y; von Bubnoff A; Ikematsu N; Blitz IL; Tsuzuku JK; Yoshida EH; Umemori H; Miyazono K; Yamamoto T; Cho KW
Mech Dev; 2003 May; 120(5):629-37. PubMed ID: 12782279
[TBL] [Abstract][Full Text] [Related]
37. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
38. The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling.
Attisano L; Silvestri C; Izzi L; Labbé E
Mol Cell Endocrinol; 2001 Jun; 180(1-2):3-11. PubMed ID: 11451566
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors.
Goto K; Kamiya Y; Imamura T; Miyazono K; Miyazawa K
J Biol Chem; 2007 Jul; 282(28):20603-11. PubMed ID: 17493940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
